The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled “Bio Pharma: Current Trends in Written Description and Enablement, and Employee Mobility” on September 22, 2021 from 11:00 am to 1:45 pm (ET). The program will consist of two panels: • Panel I — Current Topics in the Federal Circuit’s Law of Written Description and Enablement — John Josef Molenda of Steptoe & Johnson LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Henry Hadad of Bristol-Myers Squibb; Joshua Rosenkranz of Orrick, Herrington & Sutcliffe LLP; and John Whealan of The George Washington…
Want to view the entire article? Click here: FCBA Remote Program on Written Description and Enablement and Employee Mobility
The article was originally posted on Patent Docs.
Each article is copyrighted to its original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.